What is the share price of Zenith Drugs Ltd (ZENITHDRUG) today?
The share price of ZENITHDRUG as on 14th November 2025 is ₹59.30. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Zenith Drugs Ltd (ZENITHDRUG) share?
The past returns of Zenith Drugs Ltd (ZENITHDRUG) share are- Past 1 week: -0.85%
- Past 1 month: -9.30%
- Past 3 months: -7.78%
- Past 6 months: -25.41%
- Past 1 year: -40.13%
- Past 3 years: N/A%
- Past 5 years: -43.60%
What are the peers or stocks similar to Zenith Drugs Ltd (ZENITHDRUG)?
The peers or stocks similar to Zenith Drugs Ltd (ZENITHDRUG) include:What is the market cap of Zenith Drugs Ltd (ZENITHDRUG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Zenith Drugs Ltd (ZENITHDRUG) is ₹101.69 Cr as of 14th November 2025.What is the 52 week high and low of Zenith Drugs Ltd (ZENITHDRUG) share?
The 52-week high of Zenith Drugs Ltd (ZENITHDRUG) is ₹107 and the 52-week low is ₹47.15.What is the PE and PB ratio of Zenith Drugs Ltd (ZENITHDRUG) stock?
The P/E (price-to-earnings) ratio of Zenith Drugs Ltd (ZENITHDRUG) is 14.20. The P/B (price-to-book) ratio is 1.47.Which sector does Zenith Drugs Ltd (ZENITHDRUG) belong to?
Zenith Drugs Ltd (ZENITHDRUG) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Zenith Drugs Ltd (ZENITHDRUG) shares?
You can directly buy Zenith Drugs Ltd (ZENITHDRUG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Zenith Drugs Ltd
ZENITHDRUG Share Price
ZENITHDRUG Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
ZENITHDRUG Performance & Key Metrics
ZENITHDRUG Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 1.47 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.15 | 5.87 | 0.59% |
ZENITHDRUG Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
ZENITHDRUG Company Profile
Zenith Drugs is an India-based pharmaceutical manufacturing and trading company.
ZENITHDRUG Forecast
ZENITHDRUG Forecasts
ZENITHDRUG
ZENITHDRUG
Income
Balance Sheet
Cash Flow
ZENITHDRUG Income Statement
ZENITHDRUG Income Statement
| Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 78.33 | 73.51 | 92.60 | 115.76 | 133.74 | 135.93 | — | |||||||
| Raw Materials | 53.64 | 47.69 | 69.19 | 0.00 | 36.41 | 52.76 | — | |||||||
| Power & Fuel Cost | 0.03 | 0.00 | 0.00 | 1.04 | 1.09 | 1.59 | ||||||||
| Employee Cost | 3.00 | 2.41 | 2.98 | 4.96 | 5.34 | 6.76 | ||||||||
| Selling & Administrative Expenses | 9.84 | 10.95 | 9.13 | 0.00 | 15.62 | 14.84 | ||||||||
| Operating & Other expenses | 4.72 | 5.16 | 3.43 | 99.47 | 57.69 | 44.04 | ||||||||
| EBITDA | 7.10 | 7.30 | 7.87 | 10.29 | 17.59 | 15.94 | — | |||||||
| Depreciation/Amortization | 0.92 | 1.22 | 1.34 | 1.30 | 1.30 | 2.97 | — | |||||||
| PBIT | 6.18 | 6.08 | 6.53 | 8.99 | 16.29 | 12.97 | — | |||||||
| Interest & Other Items | 1.31 | 1.49 | 2.14 | 2.33 | 3.00 | 3.71 | — | |||||||
| PBT | 4.87 | 4.59 | 4.39 | 6.66 | 13.29 | 9.26 | — | |||||||
| Taxes & Other Items | 1.47 | 1.53 | 1.19 | 1.78 | 3.75 | 2.10 | — | |||||||
| Net Income | 3.40 | 3.06 | 3.20 | 4.88 | 9.54 | 7.16 | — | |||||||
| EPS | 85.00 | 76.50 | 80.00 | 122.00 | 10.87 | 4.18 | — | |||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.00 | — | |||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.05 | 0.00 | — |
ZENITHDRUG Company Updates
ZENITHDRUG Stock Peers
ZENITHDRUG Past Performance & Peer Comparison
ZENITHDRUG Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Zenith Drugs Ltd | 14.20 | 1.47 | — |
| Sun Pharmaceutical Industries Ltd | 38.57 | 5.82 | 0.91% |
| Torrent Pharmaceuticals Ltd | 67.85 | 17.08 | 0.84% |
| Cipla Ltd | 23.47 | 3.96 | 1.04% |
ZENITHDRUG Stock Price Comparison
Compare ZENITHDRUG with any stock or ETFZENITHDRUG Holdings
ZENITHDRUG Shareholdings
ZENITHDRUG Promoter Holdings Trend
ZENITHDRUG Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
ZENITHDRUG Institutional Holdings Trend
ZENITHDRUG Institutional Holdings Trend
No institutional holdings trend are available
ZENITHDRUG Shareholding Pattern
ZENITHDRUG Shareholding Pattern
ZENITHDRUG Shareholding History
ZENITHDRUG Shareholding History
smallcases containing ZENITHDRUG stock
smallcases containing ZENITHDRUG stock
Looks like this stock is not in any smallcase yet.
ZENITHDRUG Events
ZENITHDRUG Events
ZENITHDRUG Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
ZENITHDRUG Dividend Trend
No dividend trend available
ZENITHDRUG Upcoming Dividends
ZENITHDRUG Upcoming Dividends
No upcoming dividends are available
ZENITHDRUG Past Dividends
ZENITHDRUG Past Dividends
Cash Dividend
Ex DateEx DateSep 17, 2024
Dividend/Share
₹0.50
Ex DateEx Date
Sep 17, 2024
ZENITHDRUG Stock News & Opinions
ZENITHDRUG Stock News & Opinions
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2025.Powered by Capital Market - Live
Zenith Drugs announced that the 25th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 12 April 2025.Powered by Capital Market - Live
Zenith Drugs will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 11.65%, vs industry avg of 10.03%
Over the last 5 years, market share stayed at 0.03%
Over the last 5 years, net income has grown at a yearly rate of 16.06%, vs industry avg of 20.02%